The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Maximum concentration of drug in plasma (Cmax)
Timeframe: pre-dose to 24 hours
Area under the plasma concentration-time curve during dosing interval (AUCt)
Timeframe: pre-dose to 24 hours